Zoomcar (ZCAR) files Amendment No.7, adds CEO letter to Schedule TO
Rhea-AI Filing Summary
Zoomcar Holdings, Inc. amends its Schedule TO tender offer statement. This Amendment No. 7 files a Shareholder Letter dated May 20, 2026 as Exhibit (a)(1)(Q) and supplements Items 1, 4 and 11 of the Schedule TO. The remainder of the Schedule TO is incorporated by reference.
Positive
- None.
Negative
- None.
Key Figures
Amendment number: Amendment No. 7
Original Schedule TO filing date: January 23, 2026
Exhibit letter date: May 20, 2026
+2 more
5 metrics
Amendment number
Amendment No. 7
Schedule TO series of amendments
Original Schedule TO filing date
January 23, 2026
initial Schedule TO filing
Exhibit letter date
May 20, 2026
Shareholder Letter from CEO filed as Exhibit (a)(1)(Q)
Prior amendment dates
Jan 27, Feb 2, Mar 2, Mar 18, Apr 15, May 12 2026
Amendments No.1–6 referenced in Schedule TO
Exhibit added
107 (Filing Fee Table)
Item 12 was amended to add Exhibit 107
Key Terms
Schedule TO, Tender Offer, Schedule 13e-3, Shareholder Letter
4 terms
Schedule TO regulatory
"This Amendment amends and supplements the Tender Offer Statement on Schedule TO"
A phrase indicating that a company plans or intends to hold an event, publish information, or take an action at a specified future time, but that the timing is not guaranteed and may change. For investors it signals an expected milestone—like an earnings call, product launch, or filing—so think of it as a calendar note rather than a firm promise; timing shifts can affect trading, expectations, and planning.
Tender Offer financial
"Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Exchange Act"
A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.
Schedule 13e-3 regulatory
"Item 13. Information Required by Schedule 13e-3. Not applicable."
Schedule 13E-3 is a formal SEC filing that companies or their insiders must submit when proposing a buyout that would take a public company private or is otherwise a management-led purchase. It lays out who is behind the deal, the money and terms involved, any potential conflicts of interest, and independent fairness analysis so shareholders can assess whether the offer is fair—like the rulebook and disclosure packet you’d get before agreeing to sell your home.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Zoomcar's Amendment No. 7 (ZCAR) do?
It files a shareholder letter as an exhibit and supplements prior disclosures. Amendment No. 7 attaches the CEO letter dated May 20, 2026 and updates Items 1, 4 and 11 of the Schedule TO; all other Schedule TO information remains incorporated by reference.
Which exhibit was added in Zoomcar's Schedule TO amendment?
Exhibit (a)(1)(Q) — a letter from the CEO dated May 20, 2026. Item 12 was amended to add this shareholder letter and the filing also references the Filing Fee Table as Exhibit 107 in the amendment.
Does Amendment No. 7 change the core tender offer terms?
The amendment supplements Items 1, 4 and 11 by reference to the CEO letter. The filing states the Schedule TO remains unchanged except as specifically provided in this Amendment; no other revisions are described in the excerpt.
What prior filings does Amendment No. 7 reference?
It references the original Schedule TO filed January 23, 2026, and Amendments No. 1–6. Amendments cited include filings on January 27, February 2, March 2, March 18, April 15, and May 12, 2026.